Лекарство от Гепатит С

Hepcinat Plus ( Hepcinat Plus ) has been officially approved for use in combination with other antiviral drugs for the treatment of hepatitis C genotypes 1, 2, 3, and 4 in adult patients.

MyHep DVIR (MayHep Dvir) , harmoniously combining two nucleotide analogs & mdash; Sofosbuvir and Daclatasvir. These drugs are approved by the U.S. Department of Health.

HEPCVIR-L is  indicated for the treatment of chronic hepatitis C virus genotype 1 infection in adults  .

Buy Ledviklear Ledviclear is a combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C, a viral infection of the liver.

The drug Ledihep (Ledihep) is intended for the treatment of HCV of the first and fourth genotypes in patients with cirrhosis of the largest digestive gland and without it. 

 Ledikast & mdash; it is a drug from the pharmaceutical company Natco Pharma Limited, which is designed to treat 1, 4, 5, and 6 HCV genotypes. 

Sovihep D препарат, применяемый для лечения вирусного гепатита С. В состав препарата входят действующие вещества Даклатасвир 60 мг и Софосбувир 400 мг. 

Myhep ALL is a combination of velpatasvir 100 mg + Sofosbuvir 400 mg. Myhep ALL is a combination of two drugs to treat hepatitis C.

Resof Total Tablet is a combination drug used to treat chronic hepatitis C infection.

Hepcvel is a combination medicine used to treat chronic hepatitis C infection. 

Velakast (Velakast) is a tablet whose dosage is fixed, taken orally, contain sofosbuvir and velpatasvir.

Таблетка Совихеп V используется для лечения инфекции, вызванной вирусом хронического гепатита С (ВГС).

Velpanat Tablet is a combination drug used to treat chronic hepatitis C infection.

The drug  Velasof is  indicated for the treatment of 1, 2, 3, 4, 5 and 6 HCV genotypes in chronic form ( fibrosis  and  cirrhosis  are not a contraindication).

Qurled Sofosbuvir is a new-generation direct-acting antiviral drug. Qurdac Daclatasvir  is an NS5A viral protein inhibitor. It prevents the virus from entering the bloodstream.

Resof L tablet is a combination drug used to treat chronic hepatitis C infection.

MyHep LVIR Tablet - комбинированное лекарственное средство, используемое для лечения хронической инфекции гепатита С. Это лекарство следует использовать с особой осторожностью у пациентов с известной историей гепатита B из-за повышенного риска серьезных побочных реакций.

The  drug Ledifos was  created for the treatment of chronic HCV genotypes 1 and 4 in patients with and without cirrhosis.

Препарат Sofokast (Софокаст, софосбувир) - это современное противовирусное лекарство от дочернего предприятия Aprazer индийской фармацевтической компании Natco Labs Ltd.

DaciHep (Dashihep) + SoviHep (Sovihep) in a set of 6 pcs. on the course of therapy are substances that suppress or delay the course of physiological processes in chronic hepatitis C

Targeted antiviral - the drug does not interact with healthy liver cells.

Resof (Resof) + HepCfix (Hepsfix) are inhibitors for the treatment of chronic hepatitis C as a combination regimen of antiviral therapy in adult patients, either as a stand-alone kit or in combination with other medicines.

Таблетки Myhep-Mydekla - это противовирусные препараты, содержащие два наиболее распространенных ингредиента, таких как Софосбувир и Даклатасвир

Virpas is a combination of  ledipasvir and sofosbuvir  and is used to treat chronic (prolonged) hepatitis C, a viral infection of the liver.

Velpaclear Tablet - комбинированное лекарственное средство, используемое для лечения хронической инфекции гепатита С.

При комплексном лечении Гепцинат и Натдак, у пациентов наблюдается самый благоприятный прогноз.